Disparities Exist in the Application of Low Tidal-volume Ventilation in the Emergency Department.

Authors:
Self M; Kennis B; Lafree A; Tainter CR; Lopez J and 3 more

Journal:
West J Emerg Med

Publication Year: 2023

DOI:
10.5811/westjem.59291

PMCID:
PMC10284531

PMID:
37278778

Journal Information

Full Title: West J Emerg Med

Abbreviation: West J Emerg Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Emergency Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. Dr. Malhotra is funded by the National Institutes of Health (NIH). He reports income related to medical education from Eli Lilly, Jazz, Zoll, and Livanova. ResMed provided a philanthropic donation to the University of California at San Diego (UCSD). Dr. Malhotra is a cofounder of Healciscio, a medical startup forming in approval with the UCSD and in accordance with the UCSD‘s conflicts of interest management policies. Dr. Wardi has been supported by the NIH (R35GM143121, K23GM146092) in the past year. There are no conflicts of interest to declare."

Evidence found in paper:

"Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. Dr. Malhotra is funded by the National Institutes of Health (NIH). He reports income related to medical education from Eli Lilly, Jazz, Zoll, and Livanova. ResMed provided a philanthropic donation to the University of California at San Diego (UCSD). Dr. Malhotra is a cofounder of Healciscio, a medical startup forming in approval with the UCSD and in accordance with the UCSD‘s conflicts of interest management policies. Dr. Wardi has been supported by the NIH (R35GM143121, K23GM146092) in the past year. There are no conflicts of interest to declare."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025